Patents by Inventor David Aldous

David Aldous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130312316
    Abstract: The present invention provides useful cooking and/or heating fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. The fuel compositions include gases stored under pressure, liquids, and gels/gelled waxes. Gases and liquids can include dimethyl ether and one or more C2 or larger alcohols, or can include dimethyl ether and one or more C2 or larger hydrocarbons. Gels and gelled waxes can include dimethyl ether and/or one or more C1-4 alcohols and wax or a gel. Methods of making these fuel compositions, particularly from biomass-derived syngas, are also described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 28, 2013
    Applicant: Maverick Biofuels, Inc.
    Inventors: Ronald C. STITES, David ALDOUS, David S. BRADIN, Eric CUMMING
  • Publication number: 20130055628
    Abstract: The present invention provides useful fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger alcohol, such as ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutanol, or tent-butanol. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger hydrocarbons, such as propane, propylene, propyne, and propadiene, n-butane, isobutane, isobutylene, 1-butene, 2-butene, or 1,3-butadiene. Methods of making these novel DME-based fuel compositions, particularly from biomass-derived syngas, are described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.
    Type: Application
    Filed: October 19, 2012
    Publication date: March 7, 2013
    Applicant: MAVERICK BIOFUELS, INC.
    Inventors: Ronald C. STITES, David ALDOUS
  • Patent number: 8187705
    Abstract: Manganese vanadium tantalum oxide that can be represented by the formula MnxVyTazOw, where 1?x?3, 0.001?y?3, 0.001?z?2, and w=7, and alternately, x=1.25?x?2.45, 0.1?y?2.39, 0.2?z?1.9, and w=7, methods of producing MnxVyTazOw, a pigment coated with MnxVyTazOw and a chalcogenide glass layer, and a method of producing the coated pigment are described. The disclosed manganese vanadium tantalum oxide has superior near-infrared reflective properties. The disclosed methods of producing the manganese vanadium tantalum oxide provide products with superior phase purity, appearance and performance and take health and safety into consideration. The construction of the disclosed coated pigment combines the reflective properties of the substrate with the near-infrared reflective properties of MnxVyTazOw, while the chalcogenide glass layer provides aesthetic appeal. The disclosed method of producing the coated pigment involves physical vapor deposition of MnxVyTazOw and the chalcogenide glass layer.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: May 29, 2012
    Assignee: Silberline Manufacturing Company, Inc.
    Inventors: Stewart Warrender, Hai Hui Lin, Parfait Jean Marie Likibi, Rajasekar Pitchimani, Devidas Balu Raskar, David Aldous
  • Publication number: 20120047796
    Abstract: The present invention provides useful fuel compositions which may be produced substantially from renewable resources, such as biomass, to provide green fuel compositions, methods, and systems. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger alcohol, such as ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, isobutanol, or tert-butanol. In some embodiments, fuel compositions include dimethyl ether and one or more C2 or larger hydrocarbons, such as propane, propylene, propyne, and propadiene, n-butane, isobutane, isobutylene, 1-butene, 2-butene, or 1,3-butadiene. Methods of making these novel DME-based fuel compositions, particularly from biomass-derived syngas, are described. Various applications and methods of using the fuel compositions, such as portable cylinder fuels for camping, are disclosed. Additionally, principles of burner design for these fuel compositions are disclosed herein.
    Type: Application
    Filed: November 8, 2011
    Publication date: March 1, 2012
    Applicant: RANGE FUELS, INC.
    Inventors: Ronald C. STITES, David ALDOUS
  • Publication number: 20120016058
    Abstract: Manganese vanadium tantalum oxide that can be represented by the formula MnxVyTazOw, where 1?x?3, 0.001?y?3, 0.001?z?2, and w=7, and alternately, x=1.25?x?2.45, 0.1?y?2.39, 0.2?z?1.9, and w=7, methods of producing MnxVyTazOw, a pigment coated with MnxVyTazOw and a chalcogenide glass layer, and a method of producing the coated pigment are described. The disclosed manganese vanadium tantalum oxide has superior near-infrared reflective properties. The disclosed methods of producing the manganese vanadium tantalum oxide provide products with superior phase purity, appearance and performance and take health and safety into consideration. The construction of the disclosed coated pigment combines the reflective properties of the substrate with the near-infrared reflective properties of MnxVyTazOw, while the chalcogenide glass layer provides aesthetic appeal. The disclosed method of producing the coated pigment involves physical vapor deposition of MnxVyTazOw, and the chalcogenide glass layer.
    Type: Application
    Filed: July 15, 2010
    Publication date: January 19, 2012
    Applicant: SILBERLINE MANUFACTURING COMPANY, INC.
    Inventors: Stewart James WARRENDER, Hai Hui LIN, Parfait Jean Marie LIKIBI, Rajasekar PITCHIMANI, Devidas Balu RASKAR, David ALDOUS
  • Publication number: 20070203138
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: April 26, 2007
    Publication date: August 30, 2007
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Jiayo Li, David Aldous, Sukanthini Thurairatnam
  • Publication number: 20070142417
    Abstract: The present invention is directed to the substantially pure compound of formula (A), or pharmaceutically acceptable salt, or solvate of said compound; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (A), and a pharmaceutically acceptable carrier; and the use of a compound of formula (A) having activity as an inhibitor, preferably a selective inhibitor, of I?B (IKK), particularly IKK-2, and methods related thereto.
    Type: Application
    Filed: November 13, 2006
    Publication date: June 21, 2007
    Applicant: AVENTIS PHARMACEUTICALS INC
    Inventors: El-Bdaoui HADDAD, Olaf Ritzeler, David Aldous, Paul Cox
  • Publication number: 20070135386
    Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: January 22, 2007
    Publication date: June 14, 2007
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals Inc.
    Inventors: Michael Graupe, James Palmer, David Aldous, Sukanthini Thurairatnam
  • Publication number: 20070049594
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: December 7, 2005
    Publication date: March 1, 2007
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, John Patterson, David Aldous, Sukanthini Thurairatnam, Andreas Timm, John Link, Jiayao Li, Stephen Pickett, Frank Halley, Justine Lai
  • Publication number: 20060189657
    Abstract: Novel inhibitors of cathepsin S, K, B, and L, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: April 24, 2006
    Publication date: August 24, 2006
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Sukanthini Thurairatnam, David Aldous, Vincent Leroy, Andreas Timm
  • Patent number: 7064123
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Grant
    Filed: December 24, 2001
    Date of Patent: June 20, 2006
    Assignees: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, John W. Patterson, Stephen D. Pickett, John O. Link, Jiayao Li, David Aldous, Sukanthini Thurairatnam, Andreas P. Timm, Frank Halley, Justine Lai Yeun Quai
  • Publication number: 20060089357
    Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: December 7, 2005
    Publication date: April 27, 2006
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, James Palmer, John Patterson, Stephen Pickett, David Aldous, Sukanthini Thurairatnam, Andreas Timm, Frank Halley, Justine Lai, John Link, Jiayao Li
  • Publication number: 20050267044
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: June 24, 2005
    Publication date: December 1, 2005
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Jiayo Li, David Aldous, Sukanthini Thurairatnam
  • Publication number: 20050038069
    Abstract: This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; R1 represents hydrogen or a straight- or branched-chain alkyl group of 1 to about 4 carbon atoms, optionally substituted by hydroxy or one or more halogen atoms, or when Z1 represents a direct bond R1 may also represent a lower alkenyl or lower alkynyl group, or a formyl group; R2 represents hydrogen, alkenyl, alkoxy, alkyl, alkylsulphinyl, alkylsulphonyl, alkylthio, aryl, arylalkyloxy, arylalkylsulphinyl, arylalkylsulphonyl, arylalkylthio, aryloxy, arylsulphinyl, arylsulphonyl, arylthio, cyano, cycloalkenyl, cycloalkenyloxy, cycloalkyl, cycloalkyloxy, heteroaryl, heteroarylalkyloxy, heteroaryloxy, hydroxy, —SO2NR4R5, —NR4SO2R5, —NR4R5, —C(?O)R5, —C(?O)C(?O)R5, —C(?O)NR4R5, —C(?O)OR5, —O(C?O)NR4R5, or
    Type: Application
    Filed: September 1, 2004
    Publication date: February 17, 2005
    Applicant: AVENTIS PHARMA LIMITED
    Inventors: Paul Cox, Shelley Bower, David Aldous, Peter Astles, Daniel McGarry, Christopher Hulme, John Regan, Fu-Chih Huang, Stevan Djuric, Kevin Moriarty, Rose Mathew, Gregory Poli
  • Publication number: 20050009831
    Abstract: The present invention concerns compounds of general formula (I): in which: R1 represents hydrogen, R4, —C(?Y)—NHR4, —SO2NHR4, —C(=Z1)—R4, —SO2—R4 or —C(=Z1)—OR4; R2 represents hydrogen, cyano, halogen or —C?C—R5; R3 represents hydrogen, acyl, alkoxycarbonyl, alkyl, aroyl, aryl, aryloxycarbonyl, carboxy, cycloalkenyl, cycloalkyl, heteroaroyl, heteroaryl, heterocycloalkyl or —C(?O)—NY1Y2; R4 represents optionally substituted alkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, aryl or heteroaryl R5 represents hydrogen or alkyl; R6 represents alkyl, acyl, alkoxycarbonyl, alkylsulfonyl, aryl, arylsulfonyl, aroyl, cycloalkyl, cycloalkenyl, heteroaryl, heteroarylsulfonyl, heteroaroyl and heterocycloalkyl; R7 represents optionally substituted alkyl, cycloalkyl or cycloalkylalkyl, R8 represents hydrogen, alkyl, alkenyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R9 represents alkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl or heterocycloalkylalkyl;
    Type: Application
    Filed: March 18, 2004
    Publication date: January 13, 2005
    Applicant: Aventis Pharma S.A,
    Inventors: Andrew Ratcliffe, Roger Aitchison Walsh, Tahir Majid, Sukanthini Thurairatnam, Shelley Amendola, David Aldous, John Souness, Conception Nemecek, Sylvie Wentzler, Corinne Venot